|
31 |
Holter monitoring versus programmed ventricular stimulation
Enthalten in Cardiovascular drugs and therapy Bd. 4, Nr. 3, date:6.1990: 555-558
|
|
|
|
32 |
Therapie des Sinusknotensyndroms
Enthalten in Deutsche medizinische Wochenschrift Bd. 101, 1976, Nr. 05: 176-178
|
|
|
|
33 |
A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy
Enthalten in Clinical research in cardiology Bd. 96, 22.12.2006, Nr. 3, date:3.2007: 130-139
|
|
|
|
34 |
Angiotensin II Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF) Trial
Enthalten in Clinical drug investigation Bd. 27, 24.8.2012, Nr. 10, date:10.2007: 697-705
|
|
|
|
35 |
Diagnostik und Therapie von ICD-Elektrodendefekten
Enthalten in Herzschrittmachertherapie + Elektrophysiologie Bd. 19, 11.2.2009, Nr. 4, date:12.2008: 169-180
|
|
|
|
36 |
Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients
Enthalten in Journal of molecular medicine Bd. 82, 4.2.2004, Nr. 3, date:3.2004: 182-188
|
|
|
|
37 |
Genome-wide association study suggests impact of chromosome 10 rs139401390 on kidney function in patients with coronary artery disease
Enthalten in Scientific reports Bd. 9, 26.2.2019, Nr. 1, date:12.2019: 1-8
|
|
|
|
38 |
Klinik und Therapie des Brugada-Syndroms
Enthalten in Herzschrittmachertherapie + Elektrophysiologie Bd. 13, 12.2.2014, Nr. 3, date:9.2002: 157-165
|
|
|
|
39 |
Microvascular dysfunction in nonfailing arrhythmogenic right ventricular cardiomyopathy
Enthalten in European journal of nuclear medicine and molecular imaging Bd. 39, 24.11.2011, Nr. 3, date:3.2012: 416-420
|
|
|
|
40 |
Prevalence and prognostic impact of comorbidities in patients with severe aortic valve stenosis
Enthalten in Clinical research in cardiology Bd. 96, 30.10.2006, Nr. 1, date:1.2007: 23-29
|
|
Administration
